Bianchini, Michele <br/><br/>
Specific assessment of BCR-ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients.  [electronic resource] 

 -  European journal of haematology  Apr 2009 
 - 292-300 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-0609 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-0609.2008.01199.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Benzamides<br/>Chromosomes, Human, Pair 22<br/>Chromosomes, Human, Pair 9<br/>Drug Resistance, Neoplasm<br/>Female<br/>Fusion Proteins, bcr-abl--drug effects<br/>Gene Amplification<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Gene Rearrangement<br/>Humans<br/>Imatinib Mesylate<br/>In Situ Hybridization, Fluorescence<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Middle Aged<br/>Piperazines--therapeutic use<br/>Polymerase Chain Reaction<br/>Pyrimidines--therapeutic use<br/>Reverse Transcriptase Polymerase Chain Reaction